Vimarsana
Biggest News Aggregation in the World

Page 21 - End Results Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from End Results Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In End Results Program Today - Breaking & Trending Today

Sex and age differences in mortality trends of gastric cancer among Hispanic/Latino populations in the United States, Latin America, and the Caribbean - Vimarsana News

Sex and age differences in mortality trends of gastric cancer among Hispanic/Latino populations in the United States, Latin America, and the Caribbean

Overall gastric cancer mortality rates in Hispanics/Latinos declined in the last two decades. However, there was a notable variation in trends by country, sex, and age group. Continued and targeted prevention efforts are needed to reduce the disease burden in these vulnerable populations.

Incidence of Cutaneous T-Cell Lymphoma Up in the U.S. - Vimarsana News

Incidence of Cutaneous T-Cell Lymphoma Up in the U.S.

The overall incidence of cutaneous T-cell lymphoma (CTCL) increased in the United States from 2000 to 2018.

Incidence of Cutaneous T-Cell Lymphoma Up in the US - Vimarsana News

Incidence of Cutaneous T-Cell Lymphoma Up in the US

Overall incidence rate 6 times higher for patients aged 40 years or older vs younger than 40 years, but increase in CTCL rate significantly higher for those younger than 40 years.

GRAIL, LLC: GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022 - Vimarsana News

GRAIL, LLC: GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022

Adding Multi-Cancer Early Detection (MCED) Screening to Standard of Care Screening More Than Doubled the Number of Cancers Detected 71% of Participants With MCED-Detected Cancers Had Cancer Types

GRAIL, LLC: CORRECTING and REPLACING GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022 - Vimarsana News

GRAIL, LLC: CORRECTING and REPLACING GRAIL Announces Final Results From the PATHFINDER Multi-Cancer Early Detection Screening Study at ESMO Congress 2022

Please replace the release with the following corrected version. A multimedia asset accompanying this release and paragraph seven have been removed. This press release features multimedia. View the